Skip to main content
. 2013 Aug 5;5(1):60–65. doi: 10.1111/jdi.12123

Table 1. Clinical characteristics of study participants by gender.

Male Female P‐value* Total
n 52,360 (60.2%) 34,924 (39.8%) 87,284
Age (years) 42.1 ± 8.1 42.2 ± 9.0 0.8 42.1 ± 8.5
Fasting glucose (mg/dL) 95.4 ± 8.9 92.1 ± 8.1 <0.001 94.1 ± 8.7
HbA1c (%) 5.55 ± 0.26 5.54 ± 0.27 <0.001 5.55 ± 0.27
Hb (g/dL) 15.5 ± 0.8 13.2 ± 0.8 <0.001 14.5 ± 1.37
Body mass index (kg/m2) 24.4 ± 2.8 22.2 ± 3.0 <0.001 23.4 ± 3.1
Systolic BP (mmHg) 116.1 ± 11.4 111.0 ± 12.6 <0.001 114.0 ± 12.1
LDL‐C (mg/dL) 118.6 ± 27.4 106.8 ± 29.0 <0.001 113.9 ± 29.7
HDL‐C (mg/dL) 51.8 ± 11.0 61.8 ± 13.5 <0.001 55.8 ± 13.0
Triglyceride (mg/dL) 146.6 ± 91.3 94.2 ± 54.2 <0.001 125.3 ± 82.2
Total cholesterol (mg/dL) 199.3 ± 33.0 191.5 ± 33.1 <0.001 196.1 ± 33.2

Data are n (%) or means ± standard deviation. *Estimated by unpaired t‐test. BP, blood pressure; Hb, hemoglobin; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; LDL, low density lipoprotein‐cholesterol.